SEC Form 4 · accession 0001567619-18-002760
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Sep 13, 2018
Accepted (ET)
Sep 17, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 13, 2018 | S | 12,000 | $99.57 | D | 74,950 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the "Common Stock") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.